Publication | Open Access

National trends in neoadjuvant chemotherapy utilization in patients with early-stage node-negative triple-negative breast cancer: the impact of the CREATE-X trial

Breast OncologyMedicineCancer ManagementClinical TrialsBreast CancerCreate-x TrialNeoadjuvant Chemotherapy UtilizationNational TrendsCancer TreatmentOncologyRadiation OncologyRadiologyHealth Sciences